The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology : Expert Recommendations for Better Management and Optimization
Chico, Ana (Institut de Recerca Sant Pau)
Moreno-Fernández, Jesús (Hospital General Universitario de Ciudad Real)
Fernández-García, Diego (Instituto de Salud Carlos III)
Solá, Eva (Universitat de València)
Universitat Autònoma de Barcelona

Fecha:	2024
Resumen:	Technological advances in the management of diabetes, especially type 1 diabetes (T1D), have played a main role in significantly improving glycemic control of these patients in recent years. Undoubtedly, the most important advance has been the commercialization of hybrid closed-loop systems (HCL). Their effectiveness places them in the different guidelines from scientific societies as the gold standard for the treatment of people with T1D. However, obtaining the maximum performance from these systems requires a degree of expertise from the professionals who care for these patients. Specifically, the Tandem X2:slim with Control-IQ technology system, due to its features and configuration options and adjustments, allows T1D patients to better adapt the management of diabetes to multiple circumstances in their day-to-day life. It is necessary, however, to follow a systematic process to start the system and also for the subsequent follow-up, which allows its optimization in the shortest possible time. This expert recommendation reviews the main features of this HCL system, suggesting how to implement it and optimize its use after gaining experience treating many patients.
Derechos:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original.
Lengua:	Anglès
Documento:	Article ; recerca ; Versió publicada
Materia:	Artificial pancreas ; Automated insulin delivery ; Continuous glucose monitoring ; Control-IQ technology ; Hybrid closed-loop system ; Insulin pump ; Multiple daily injections ; Time in range ; Type 1 diabetes
Publicado en:	Diabetes Therapy, Vol. 15 Núm. 1 (january 2024) , p. 281-295, ISSN 1869-6961

DOI: 10.1007/s13300-023-01486-2
PMID: 37857988

15 p, 1.5 MB

El registro aparece en las colecciones:
Documentos de investigación > Documentos de los grupos de investigación de la UAB > Centros y grupos de investigación (producción científica) > Ciencias de la salud y biociencias > Institut de Recerca Sant Pau
Artículos > Artículos de investigación
Artículos > Artículos publicados